Filter
562
Filtered Results: 562
Text search:
pharmacovigilance
Featured
Recommendations
65
New Publications
165
Language
Document type
No document type
268
Guidelines
115
Studies & Reports
80
Strategic & Response Plan
29
Manuals
28
Fact sheets
16
Resource Platforms
8
Training Material
7
Situation Updates
4
Online Courses
4
Infographics
2
Videos
1
Countries / Regions
Kenya
26
Congo, Democratic Republic of
17
South Africa
17
Ghana
16
India
16
Nigeria
15
Global
14
Western and Central Europe
14
Uganda
14
Senegal
12
Eastern Europe
12
Rwanda
11
Ethiopia
11
Nepal
10
Latin America and the Carribbean
10
Namibia
10
West and Central Africa
9
Sierra Leone
8
Burkina Faso
8
Malawi
8
Tanzania
8
East and Southern Africa
8
Zambia
8
Madagascar
8
Africa
7
Benin
6
Haiti
6
South–East Asia Region
6
Philippines
5
Cambodia
5
Bangladesh
5
Russia
5
Botswana
5
Liberia
5
Middle East and North Africa
4
Ukraine
3
Lesotho
3
Zimbabwe
3
Mozambique
3
Eastern Europe and Central Asia
3
Chile
2
Cameroon
2
Syria
2
Morocco
2
Asia
2
Paraguay
2
Lebanon
2
Brazil
2
Sudan
2
Chad
2
Libya
2
Indonesia
2
Myanmar / Burma
2
Eswatini/ Swaziland
2
Pakistan
2
Thailand
1
Gambia
1
Laos
1
Afghanistan
1
Burundi
1
Guinea
1
Jordan
1
Western Pacific Region
1
France
1
Maldives
1
Southern Africa
1
Argentina
1
Sri Lanka
1
Yemen
1
Georgia
1
Mali
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
281
Clinical Guidelines
63
Public Health
18
Pharmacy & Technologies
10
Capacity Building
8
Women & Child Health
8
Key Resources
7
Toolboxes
Pharmacy
73
COVID-19
62
TB
55
AMR
46
NTDs
27
HIV
23
Rapid Response
6
Ebola & Marburg
6
Caregiver
5
Planetary Health
5
NCDs
4
Refugee
3
Specific Hazards
2
Global Health Education
2
Cholera
1
Conflict
1
Zika
1
Polio
1
Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have access to health facilities or a qualified health care provider and do not receive the necessary care in a...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
WHO Guidelines for the Treatment of Human African Trypanosomiasis. Web Annex B
The toolkit is a collection of assessment tools and checklists that describe the key considerations to be taken into account when transitioning to Option B/B+. The toolkit provides a roadmap to support the planning and implementation of Option B/B+, and to help countries scale up more effective inte...
The WHO Cholera Vaccine Position Paper (August 2017) highlights the importance of oral cholera vaccines (OCVs) as a key tool in outbreak response and prevention, alongside water, sanitation, and hygiene (WASH) measures. It recommends OCVs for high-risk populations, endemic areas, and humanitarian cr...
This annual report gives an overview of WHO lesotho Country office's undertakings and achievements in the context of an extraordinary health emergency. As we walk another mile this year, may we embrace all lessonst leanred in the previous year, learn from what did not work so well and take on new op...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri...
This Pharmaceutical Country Profile for Kenya (2010) has been developed by the Ministry of Medical Services with support of the World Health Organization. The Profile contains information on existing socio-economic and health-related conditions, resources, regulatory structures and processes and out...
This document provides a decision-making framework for implementation of mass treatment interventions, active case-finding campaigns and population-based surveys for neglected tropical diseases in the context of the COVID-19 pandemic. A two-step approach is proposed: a risk–benefit assessment, to ...
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of CVD diseases. Affordable essential medicines and t...
